After recent updates from the FDA
OKLAHOMA CITY - The Oklahoma State Department of Health (OSDH) is committed to sharing the most up to date and timely information about the COVID-19 pandemic.
Monday, the FDA removed the authorization for the use of two monoclonal antibody treatments that have been on the market, REGEN-COV and Bam/Ete, due to their ineffectiveness against the omicron variant, taking into consideration the prevalence of omicron in the country.
Right now, in Oklahoma, our sequencing surveillance shows us 98% of cases are attributable to the omicron variant.
The National Institutes of Health (NIH) currently recommends four treatments for COVID-19. Listed in order of preference those are Paxlovid, Sotrovimab, Remdesivir and Molnupiravir.
“We know that the supply of these treatments is limited across the country,” said Keith Reed, interim commissioner of health. “We want Oklahomans to know that despite the limited supply, our team is doing everything we can to secure these treatments for our state.”
Individuals seeking Paxlovid, Sotrovimab and Molnupiravir can utilize the OK Therapeutics Locator Tool here to find providers nearby.
Oklahomans will need to call a site directly or speak with their healthcare provider for access to these treatments, rather than showing up to a site seeking them.
Individuals seeking out Remdesivir will also need to speak with their healthcare provider to discuss eligibility and access options. This product is not allocated through the state by the OSDH.
We want to also take time to remind Oklahomans that our healthcare systems are currently experiencing a high number of COVID hospitalizations, paired with some of our most severe staffing shortages. If you are seeking testing, please utilize county health departments, pharmacies or healthcare provider offices. Testing locations can be found here.
The Oklahoma State Department of Health (OSDH) protects and improves public health through its system of local health services and strategies focused on preventing disease. OSDH provides technical support and guidance to 68 county health departments in Oklahoma, as well as guidance and consultation to the two independent city-county health departments in Oklahoma City and Tulsa. Learn more at Oklahoma.gov/health.
###
